Donna E. Hansel

26.4k total citations · 3 hit papers
182 papers, 6.9k citations indexed

About

Donna E. Hansel is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Donna E. Hansel has authored 182 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Surgery, 52 papers in Oncology and 46 papers in Molecular Biology. Recurrent topics in Donna E. Hansel's work include Bladder and Urothelial Cancer Treatments (84 papers), Urinary and Genital Oncology Studies (71 papers) and Urological Disorders and Treatments (27 papers). Donna E. Hansel is often cited by papers focused on Bladder and Urothelial Cancer Treatments (84 papers), Urinary and Genital Oncology Studies (71 papers) and Urological Disorders and Treatments (27 papers). Donna E. Hansel collaborates with scholars based in United States, Canada and Italy. Donna E. Hansel's co-authors include Mahul B. Amin, Betty Eipper, Gabriele V. Ronnett, Jonathan I. Epstein, Anirban Maitra, Gladell P. Paner, Andrew J. Stephenson, Rodolfo Montironi, Steven C. Campbell and Christina B. Ching and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Oncology.

In The Last Decade

Donna E. Hansel

175 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

2015 429 citations Donna E. Hansel et al. profile →
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers

2018 410 citations Gladell P. Paner, Walter M. Stadler et al. European Urology profile →
Bladder cancer

2023 212 citations Lars Dyrskjøt, Donna E. Hansel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna E. Hansel United States	48	3.3k	2.1k	1.9k	1.6k	835	182	6.9k
Gaëlle Fromont France	35	1.1k 0.3×	1.7k 0.8×	825 0.4×	2.0k 1.2×	238 0.3×	163	4.8k
David Waltregny Belgium	38	1.3k 0.4×	2.3k 1.1×	1.0k 0.5×	932 0.6×	439 0.5×	98	5.1k
Gustavo E. Ayala United States	32	846 0.3×	1.8k 0.8×	1.3k 0.7×	1.8k 1.1×	206 0.2×	57	4.7k
Jessica Hicks United States	59	1.3k 0.4×	4.7k 2.2×	2.6k 1.3×	4.7k 2.9×	123 0.1×	157	9.7k
Lawrence Zukerberg United States	47	1.9k 0.6×	3.4k 1.6×	3.9k 2.0×	1.0k 0.6×	57 0.1×	155	9.6k
Rachel H. Giles Netherlands	49	1.1k 0.3×	6.2k 2.9×	1.6k 0.8×	2.4k 1.5×	112 0.1×	123	9.2k
Akiteru Goto Japan	35	568 0.2×	1.9k 0.9×	973 0.5×	684 0.4×	205 0.2×	134	3.7k
Susan E. Crawford United States	31	527 0.2×	3.7k 1.7×	832 0.4×	636 0.4×	156 0.2×	92	5.9k
Zenya Naito Japan	39	962 0.3×	1.9k 0.9×	1.2k 0.6×	697 0.4×	90 0.1×	248	4.5k
W. Böcker Germany	38	918 0.3×	1.8k 0.8×	1.3k 0.7×	576 0.4×	87 0.1×	183	4.7k

Countries citing papers authored by Donna E. Hansel

Since Specialization

Citations

This map shows the geographic impact of Donna E. Hansel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna E. Hansel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna E. Hansel more than expected).

Fields of papers citing papers by Donna E. Hansel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna E. Hansel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna E. Hansel. The network helps show where Donna E. Hansel may publish in the future.

Co-authorship network of co-authors of Donna E. Hansel

This figure shows the co-authorship network connecting the top 25 collaborators of Donna E. Hansel. A scholar is included among the top collaborators of Donna E. Hansel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna E. Hansel. Donna E. Hansel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siefker‐Radtke, Arlene O., Lianchun Xiao, Nathaniel R. Wilson, et al.. (2025). Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract. Cancer Medicine. 14(2). e70594–e70594.

Wilson, Nathaniel R., Lianchun Xiao, Jianjun Gao, et al.. (2024). Prognostic factors of relapse in surgically resected small cell neuroendocrine carcinomas of the urothelial tract (SCNEC-URO).. Journal of Clinical Oncology. 42(16_suppl). 4605–4605. 1 indexed citations

Guo, Ming, et al.. (2024). Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. American Journal of Clinical Pathology. 162(5). 492–499. 1 indexed citations

Chen, Hui, Jianping Zhao, Sinchita Roy‐Chowdhuri, et al.. (2024). Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases. Human Pathology. 148. 1–6. 3 indexed citations

Grivas, Petros, et al.. (2022). Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. Cancers. 14(6). 1555–1555. 27 indexed citations

Sottnik, Joseph L., Lauren A. Vanderlinden, Molishree Joshi, et al.. (2021). Androgen Receptor Regulates CD44 Expression in Bladder Cancer. Cancer Research. 81(11). 2833–2846. 32 indexed citations

Bindayı, Ahmet, Michelle McDonald, Alp Tuna Beksaç, et al.. (2018). Can multiphase CT scan distinguish between papillary renal cell carcinoma type 1 and type 2?. SHILAP Revista de lepidopterología. 44(4). 316–322. 4 indexed citations

Paner, Gladell P., Walter M. Stadler, Donna E. Hansel, et al.. (2018). Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. European Urology. 73(4). 560–569. 410 indexed citations breakdown →

Duex, Jason E., Charles R. Owens, Garrett M. Dancik, et al.. (2017). Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis. Cancer Research. 77(18). 4858–4867. 22 indexed citations

10.

Flaig, Thomas W., Ashish M. Kamat, Donna E. Hansel, et al.. (2017). Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium. Bladder Cancer. 3(3). 211–223. 3 indexed citations

11.

Sahu, Divya, Sounak Gupta, Andrew M. Hau, et al.. (2016). Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. American Journal Of Pathology. 187(1). 200–213. 25 indexed citations

12.

Solomon, James P., A. Karim Kader, J. Kellogg Parsons, et al.. (2016). Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?. Urology. 102. 7–16. 13 indexed citations

13.

Zhou, Ning, Kamini Singh, Maria Carmen Mir, et al.. (2013). The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo. Clinical Cancer Research. 19(7). 1717–1728. 76 indexed citations

14.

Hansel, Donna E.. (2012). The urinary tract : a comprehensive guide to patient diagnosis and management. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 4 indexed citations

15.

Overdevest, Jonathan B., Shibu Thomas, Glen Kristiansen, et al.. (2011). CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization. Cancer Research. 71(11). 3802–3811. 97 indexed citations

16.

Samplaski, Mary K., Warren D.W. Heston, Paul Elson, Cristina Magi‐Galluzzi, & Donna E. Hansel. (2011). Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Modern Pathology. 24(11). 1521–1529. 50 indexed citations

17.

Ching, Christina B., Mohammed A. Amin, Raymond R. Tubbs, et al.. (2011). HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Modern Pathology. 24(8). 1111–1119. 83 indexed citations

18.

Hansel, Donna E., Mohammed S. Orloff, Jessica Hicks, et al.. (2010). Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma. American Journal Of Pathology. 176(6). 3062–3072. 67 indexed citations

19.

Stephenson, Andrew J., Michael Gong, Steven C. Campbell, Amr Fergany, & Donna E. Hansel. (2009). Aggregate Lymph Node Metastasis Diameter and Survival After Radical Cystectomy for Invasive Bladder Cancer. Urology. 75(2). 382–386. 23 indexed citations

20.

Hansel, Donna E., Ayman Rahman, Manuel Hidalgo, et al.. (2003). Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology. American Journal Of Pathology. 163(1). 217–229. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact